Mitochondrial Complex I and III Gene MRNA Levels in Schizophrenia, and Their Relationship with Clinical Features

Overview

Journal J Mol Psychiatry

Publisher Biomed Central

Specialty Psychiatry

Date 2015 Feb 26

PMID 25713723

Citations 18

Authors

Suleyman Akarsu

Deniz Torun

Abdullah Bolu

Murat Erdem

Salih Kozan

Mehmet Ak

Hatice Akar

Ozcan Uzun

Affiliations

Soon will be listed here.

Abstract

Background: The etiology of schizophrenia is not precisely known; however, mitochondrial function and cerebral energy metabolism abnormalities were determined to be possible factors associated with the etiology of schizophrenia. Impaired mitochondrial function negatively affects neuronal plasticity, and can cause cognitive deficits and behavioral abnormalities observed during the clinical course of schizophrenia. The present study aimed to investigate the relationship between the clinical features of schizophrenia, and mitochondrial complex activation, based on measurement of mRNA levels in the NDUFV1, NDUFV2, NDUFS1, and UQCR10 genes involved in the peripheral mitochondrial complex.

Methods: The study included 138 schizophrenia patients and 42 healthy controls. The schizophrenia group was divided into a chronic schizophrenia subgroup (n = 84) and a first-episode schizophrenia subgroup (n = 54). The symptoms profile and severity of disorder were evaluated using the Scale for the Assessment of Negative Symptoms (SANS), Scale for the Assessment of Positive Symptoms (SAPS), and Brief Psychiatric Rating Scale (BPRS).

Results: The level of mRNA expression of NDUFV1, NDUFV2, and NDUFS1 was significantly higher in the schizophrenia group than in the control group. The mRNA level of NDUFV2 was positively correlated with BPRS and SAPS scores in the first-episode schizophrenia subgroup.

Conclusion: The findings showed that there was a positive correlation between gene mRNA levels and psychotic symptomatology, especially positive symptoms. Our results suggest that mRNA levels of the NDUFV1, NUDFV2, and NDUFS1 genes of complex I of the mitochondrial electron transport chain might become a possible peripheral marker for the diagnosis of schizophrenia.

Citing Articles

Circulating Cell-Free Mitochondrial DNA in Plasma of Individuals with Schizophrenia and Cognitive Deficit in Mexican Population.

Garcia-de la Cruz D, Juarez-Rojop I, Tovilla-Zarate C, Nicolini H, Genis-Mendoza A Neuropsychiatr Dis Treat. 2024; 20:1757-1765.

PMID: 39323935 PMC: 11423824. DOI: 10.2147/NDT.S460554.

Acetylome analyses provide novel insights into the effects of chronic intermittent hypoxia on hippocampus-dependent cognitive impairment.

Liu F, Yan W, Chen C, Zeng Y, Kong Y, He X Front Mol Neurosci. 2024; 17:1324458.

PMID: 38455734 PMC: 10917988. DOI: 10.3389/fnmol.2024.1324458.

Transcriptomic analysis reveals mitochondrial pathways associated with distinct adolescent behavioral phenotypes and stress response.

Santos-Silva T, Hazar Ulgen D, Lopes C, Guimaraes F, Alberici L, Sandi C Transl Psychiatry. 2023; 13(1):351.

PMID: 37978166 PMC: 10656500. DOI: 10.1038/s41398-023-02648-3.

The druggable schizophrenia genome: from repurposing opportunities to unexplored drug targets.

Lago S, Bahn S NPJ Genom Med. 2022; 7(1):25.

PMID: 35338153 PMC: 8956592. DOI: 10.1038/s41525-022-00290-4.

The Etiology of Auditory Hallucinations in Schizophrenia: From Multidimensional Levels.

Shao X, Liao Y, Gu L, Chen W, Tang J Front Neurosci. 2021; 15:755870.

PMID: 34858129 PMC: 8632545. DOI: 10.3389/fnins.2021.755870.

References

Ben-Shachar D, Nadri C, Karry R, Agam G . Mitochondrial complex I subunits are altered in rats with neonatal ventral hippocampal damage but not in rats exposed to oxygen restriction at neonatal age. J Mol Neurosci. 2008; 38(2):143-51. DOI: 10.1007/s12031-008-9144-9. View

Taurines R, Thome J, Duvigneau J, Forbes-Robertson S, Yang L, Klampfl K . Expression analyses of the mitochondrial complex I 75-kDa subunit in early onset schizophrenia and autism spectrum disorder: increased levels as a potential biomarker for early onset schizophrenia. Eur Child Adolesc Psychiatry. 2009; 19(5):441-8. DOI: 10.1007/s00787-009-0074-z. View

Barrientos A, Marin C, Miro O, Casademont J, Gomez M, Nunes V . Biochemical and molecular effects of chronic haloperidol administration on brain and muscle mitochondria of rats. J Neurosci Res. 1998; 53(4):475-81. DOI: 10.1002/(SICI)1097-4547(19980815)53:4<475::AID-JNR9>3.0.CO;2-3. View

Buchsbaum M, Buchsbaum B, Hazlett E, Haznedar M, Newmark R, Tang C . Relative glucose metabolic rate higher in white matter in patients with schizophrenia. Am J Psychiatry. 2007; 164(7):1072-81. DOI: 10.1176/ajp.2007.164.7.1072. View

Ben-Shachar D, Laifenfeld D . Mitochondria, synaptic plasticity, and schizophrenia. Int Rev Neurobiol. 2004; 59:273-96. DOI: 10.1016/S0074-7742(04)59011-6. View

Ben-Shachar D, Zuk R, Gazawi H, Reshef A, Sheinkman A, Klein E . Increased mitochondrial complex I activity in platelets of schizophrenic patients. Int J Neuropsychopharmacol. 2001; 2(4):245-253. DOI: 10.1017/S1461145799001649. View

Maurer I, Moller H . Inhibition of complex I by neuroleptics in normal human brain cortex parallels the extrapyramidal toxicity of neuroleptics. Mol Cell Biochem. 1997; 174(1-2):255-9. View

Hartmann N, Reichwald K, Wittig I, Drose S, Schmeisser S, Luck C . Mitochondrial DNA copy number and function decrease with age in the short-lived fish Nothobranchius furzeri. Aging Cell. 2011; 10(5):824-31. DOI: 10.1111/j.1474-9726.2011.00723.x. View

Richter C, Gogvadze V, Laffranchi R, Schlapbach R, Schweizer M, Suter M . Oxidants in mitochondria: from physiology to diseases. Biochim Biophys Acta. 1995; 1271(1):67-74. DOI: 10.1016/0925-4439(95)00012-s. View

10.

Calabresi P, Gubellini P, Picconi B, Centonze D, Pisani A, Bonsi P . Inhibition of mitochondrial complex II induces a long-term potentiation of NMDA-mediated synaptic excitation in the striatum requiring endogenous dopamine. J Neurosci. 2001; 21(14):5110-20. PMC: 6762835. View

11.

Ben-Shachar D, Karry R . Neuroanatomical pattern of mitochondrial complex I pathology varies between schizophrenia, bipolar disorder and major depression. PLoS One. 2008; 3(11):e3676. PMC: 2579333. DOI: 10.1371/journal.pone.0003676. View

12.

Balijepalli S, Boyd M, Ravindranath V . Inhibition of mitochondrial complex I by haloperidol: the role of thiol oxidation. Neuropharmacology. 1999; 38(4):567-77. DOI: 10.1016/s0028-3908(98)00215-9. View

13.

Hwang A, Jeong D, Lee S . Mitochondria and organismal longevity. Curr Genomics. 2013; 13(7):519-32. PMC: 3468885. DOI: 10.2174/138920212803251427. View

14.

Iwamoto K, Bundo M, Kato T . Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Hum Mol Genet. 2004; 14(2):241-53. DOI: 10.1093/hmg/ddi022. View

15.

Prabakaran S, Swatton J, Ryan M, Huffaker S, Huang J, Griffin J . Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry. 2004; 9(7):684-97, 643. DOI: 10.1038/sj.mp.4001511. View

16.

Dror N, Klein E, Karry R, Sheinkman A, Kirsh Z, Mazor M . State-dependent alterations in mitochondrial complex I activity in platelets: a potential peripheral marker for schizophrenia. Mol Psychiatry. 2002; 7(9):995-1001. DOI: 10.1038/sj.mp.4001116. View

17.

Karry R, Klein E, Ben Shachar D . Mitochondrial complex I subunits expression is altered in schizophrenia: a postmortem study. Biol Psychiatry. 2004; 55(7):676-84. DOI: 10.1016/j.biopsych.2003.12.012. View

18.

Mehler-Wex C, Duvigneau J, Hartl R, Ben-Shachar D, Warnke A, Gerlach M . Increased mRNA levels of the mitochondrial complex I 75-kDa subunit. A potential peripheral marker of early onset schizophrenia?. Eur Child Adolesc Psychiatry. 2006; 15(8):504-7. DOI: 10.1007/s00787-006-0560-5. View

19.

Albensi B, Sullivan P, Thompson M, Scheff S, Mattson M . Cyclosporin ameliorates traumatic brain-injury-induced alterations of hippocampal synaptic plasticity. Exp Neurol. 2000; 162(2):385-9. DOI: 10.1006/exnr.1999.7338. View

20.

Prince J, Yassin M, Oreland L . A histochemical demonstration of altered cytochrome oxidase activity in the rat brain by neuroleptics. Eur Neuropsychopharmacol. 1998; 8(1):1-6. DOI: 10.1016/s0924-977x(97)00036-9. View